SMTL ID : 7czd.1 (1 other biounit)

Crystal structure of PD-L1 in complex with a VHH

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

hetero-1-1-mer

Ligands

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: F.27, T.28, Y.32 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.28, A:Y.32 EDO.2: 4 residues within 4Å: Chain B: L.70, L.71, K.72, D.73 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:K.72, B:K.72, B:D.73, B:D.73 Water bridges: B:L.70 EDO.3: 4 residues within 4Å: Chain B: D.32, A.35, Y.101, G.102 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:D.32, B:D.32, B:Y.101 Water bridges: B:G.102

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhai, T. et al., Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer. J Immunother Cancer (2021)

Release Date

2021-07-14

Peptides

anti-PD-L1 VHH: A
Programmed cell death 1 ligand 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

anti-PD-L1 VHH

Programmed cell death 1 ligand 1

Related Entries With Identical Sequence